TriangleFOR PATIENTS · SOURCE READING
Treatment of Recurrent Acute Promyelocytic Leukemia
Source: Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 16, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Treatment of recurrent acute promyelocytic leukemia (APL) may include:
Source links and citations
arsenic trioxide (ATO) with or without chemotherapy
Source links and citations
stem cell transplant using the patient's stem cells or donor stem cells
Source links and citations
Learn more about these treatments in the Treatment Option Overview.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice